Cerebrospinal fluid indoleacetic acid in autistic subjects

descriptionPublicationkeyboard_double_arrow_right Article 01 Jun 1988 English Publisher:Springer Science and Business Media LLCJournal:Journal of Autism and Developmental Disorders, volume 18, pages 259-262 (issn: 0162-3257, eissn: 1573-3432,

Copyright policy )

Authors: G M, Anderson; D L, Ross; W, Klykylo; F C, Feibel; D J, Cohen;

doi: 10.1007/bf02211951

pmid: 3410814

Cerebrospinal fluid indoleacetic acid in autistic subjects

- Summary
- Subjects
- Metrics

Abstract

Cerebrospinal fluid (CSF) levels of the tryptamine metabolite, indoleacetic acid (IAA), have been measured in groups of autistic and control subjects. No significant difference was seen in group mean (+/- SEM) levels of CSF IAA (autistics 5.53 +/- 0.47 ng/ml, N = 10). The finding indicates that central metabolism of the behaviorally active trace amine tryptamine is probably normal in autism.

Related Organizations

University of Cincinnati
United States
University System of Ohio
United States
Yale University
United States

Keywords

Adult, Adolescent, Indoleacetic Acids, Infant, Newborn, Humans, Autistic Disorder, Child

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	15
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average